MR. DAVID F WILSON, L.M.S.W.
Hospitals at Brookdale Plz, Brooklyn, NY

License number
New York 72082028
Category
Hospitals
Type
General Acute Care Hospital
Address
Address 2
1 Brookdale Plz, Brooklyn, NY 11212
140 Timber Ridge Dr, Staten Island, NY 10306
Phone
(718) 240-5000
(718) 240-5990 (Fax)
(718) 682-1235

Personal information

See more information about DAVID F WILSON at radaris.com
Name
Address
Phone
David Wilson, age 86
5032 Ridge Rd, Lockport, NY 14094
David Wilson, age 48
496 Henderson Ave, Staten Island, NY 10310
(718) 273-8445
David Wilson
496 Madison Ave Apt 1, Albany, NY 12208
(518) 878-5840
David Wilson, age 57
4949 Bear Rd, Liverpool, NY 13088
David Wilson, age 73
4 Long St, Huntington Station, NY 11746
(631) 427-8437

Professional information

David Wilson Photo 1

David Wilson - Brooklyn, NY

Work:
Morgan Stanley Smith Barney - Purchase, NY
Assistant Vice President, Product Manager - 529 Plans, Offshore Mutual Funds
Citi Smith Barney - New York, NY
Vice President, Product Manager - 529 Plans
Unit Investment Trusts
Assistant Vice President, Product Specialist
JP Morgan Chase Bank - Brooklyn, NY
Fund Administrator/ Accountant
Education:
Clark Atlanta University
Bachelor of Business Administration in Finance & Marketing
Skills:
Product Management, Product Development, Team Player, Detail Oreiented,


David Wilson Photo 2

David Wilson - Brooklyn, NY

Work:
M&Ms Retail Store
SALES ASSOCIATE
Toys R Us - New York, NY
Assistant Manager
Radio City Music Hall - New York, NY Brooklyn Cyclones Professional Baseball Team - Brooklyn, NY
RADIO BOARD OPERATOR
American Specialties Inc. - Brooklyn, NY
Packer
District Council 37, AFSCME - New York, NY
Education:
Brooklyn College Brooklyn - New York, NY
BA in Business Managment
City College of New York New York - New York, NY Kingsborough Community College Brooklyn - New York, NY
A.A. in communications
Skills:
Management, Computer, Telephone, Filing, Costumer Relations


David Wilson Photo 3

David Wilson - Brooklyn, NY

Work:
Nomura Securities International
Associate /AVP OTC Derivatives, Repo, MBS, Equities, Collateral Management
Nomura Securities International - New York, NY
Collateral Management Analyst OTC Derivatives, Repo, MBS, ETFs
Nomura Securities International - New York, NY
Equity Sales Support Middle Office Analyst
Nomura Securities International - New York, NY
Reconciliation Control Operations Analyst
Japan Exchange and Teaching Program (JET) - Kagawa Prefecture, Japan
Assistant Language Teacher
Berkshire Hills Music Academy - South Hadley, MA
Artist Development Manager
Education:
The George Washington University - Washington, DC
Bachelor of Arts
University of Cape Town - Cape Town, Western Cape


David Wilson Photo 4

David Wilson - Brooklyn, NY

Work:
Kingsway Exterminating Company, Inc
Office Manager & Compliance Officer
Kingsway Exterminating Company, Inc - Brooklyn, NY
Customer Service Agent
Kingsway Exterminating Company, Inc - Brooklyn, NY
Field Technician


David F Wilson Photo 5

David F Wilson, Brooklyn NY - LCSW

Specialties:
Social Work, Clinical Social Work
Address:
207 Berkeley Pl, Brooklyn 11217
Languages:
English


David Wilson Photo 6

Cyclic Benzimidazole Derivatives Useful As Anti-Diabetic Agents

US Patent:
8394969, Mar 12, 2013
Filed:
Sep 21, 2009
Appl. No.:
12/563782
Inventors:
Brett C. Bookser - San Diego CA, US
Qun Dang - San Diego CA, US
Tony S. Gibson - San Diego CA, US
Hongjian Jiang - San Diego CA, US
De Michael Chung - Rowland Heights CA, US
Jianming Bao - Princeton NJ, US
Jinlong Jiang - Scotch Plains NJ, US
Andy Kassick - Scotch Plains NJ, US
Ahmet Kekec - Hoboken NJ, US
Ping Lan - Dayton NJ, US
Huagang Lu - Plainsboro NJ, US
Gergely M. Makara - Budapest, HU
F. Anthony Romero - Westfield NJ, US
Iyassu Sebhat - Jersey City NJ, US
David Wilson - Brooklyn NY, US
Dariusz Wodka - Monmouth Junction NJ, US
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:
A61K 31/4184, C07D 235/26, C07D 235/28, C07D 235/30
US Classification:
5483064, 514387, 514388
Abstract:
Novel compounds of the structural formula (I) are activators of AMP-protein kinase and are useful in the treatment, prevention and suppression of diseases mediated by the AMPK-activated protein kinase. The compounds of the present invention are useful in the treatment of Type 2 diabetes, hyperglycemia, metabolic syndrome, obesity, hypercholesterolemia, and hypertension.